Robuta

Ibrahim O. Sawaid and colleagues evaluate the association between the use of proton pump inhibitors and upper gastrointestinal cancer with a focus on...

Patients who use proton pump inhibitors for seven or more years to treat reflux, peptic ulcers and other conditions are at greater risk of osteoporosis-related...

Previous and current gastric acid inhibitor use was significantly associated with the presence of vitamin B12 deficiency. These findings should be considered...

Peptic ulcer disease (PUD) remains one of the most common gastrointestinal disorders, with approximately 8 million cases worldwide reported in 2019 [

Short-term PPI therapy reduces gallbladder motility in healthy volunteers. Chronic PPI therapy may pose a risk for long-term gallbladder dysfunction and...

A significant percentage of patients with gastroesophageal reflux disease (GERD) will not respond to proton pump inhibitor (PPI) therapy. The causes of...

Health Deals - Buy DG HEALTH Lansoprazole Delayed Release Capsules, 15 mg, Proton Pump Inhibitor, Treats Frequent Heartburn, 24 Hour, 14 Count - available at...

We conducted this systematic review with the objective to understand the efficacy and safety of proton pump inhibitors [PPIs] in the pediatric population. We...

Proton pump inhibitors (PPIs) are widely prescribed medications for the management of acid-related disorders, due to their effectiveness and favorable pharma...

Proton-pump inhibitors (PPIs) are the most administered first-line treatment for eosinophilic esophagitis (EoE). However, only around half of EoE patients...

The Global Proton Pump Inhibitors Market, valued at USD 3.08B in 2023, is projected to reach USD 4.04B by 2029, growing at a 4.7% CAGR.

Proton Pump Inhibitors and Dementia Incidence

Talcum powder lawsuits against Johnson & Johnson skyrocketed in 2019, along with cases against makers of acid-reducing drugs called proton pump inhibitors.

PPIs create dysbiosis of the microbiome in the mouth, gut and lungs in the paediatric population. Probiotics could restore dysbiosis but it has very poorly...

Background: The latest guidelines recommend the use of proton pump inhibitors (PPI) to minimize gastrointestinal bleeding (GIB) in patients receiving dual an...

Researchers investigated the group of microorganisms classified as Asgard archaea, and found a protein in their membrane which acts as a miniature...

Vonoprazan has considerable efficacy in initial and maintained healing of grade C/D esophagitis compared with PPI, with moderate short-term and long-term...

For a healthy Belgium: indicators of health and care

A clinical research team from Japan examined the effects of long-term proton pump inhibitor (PPI) therapy on body weight (BW) and body mass index in patients...

Proton pump inhibitors (PPIs) are recommended as a first-line treatment for gastroesophageal reflux disease (GERD) and other acid related disorders.

A total of 56 healthy Japanese males were enrolled in single- or multiple- dose pharmacokinetic trials of intravenous lansoprazole administration. The...